Cargando…

Association between peroxisome proliferator-activated receptor γ-2 gene Pro12Ala polymorphisms and risk of hypertension: an updated meta-analysis

Previous studies investigate the relationship between peroxisome proliferator-activated receptor γ-2 (PPAR) gene Pro12Ala polymorphisms and risk of hypertension. However, the number of available studies was extremely limited. We updated this evidence and gave more significant results. We performed c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Miao, Zhang, Jianping, Li, Lifeng, Wang, Qiang, Feng, Limin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393226/ https://www.ncbi.nlm.nih.gov/pubmed/30777927 http://dx.doi.org/10.1042/BSR20190022

Ejemplares similares

Genotyping of peroxisome proliferator-activated receptor gamma (PPAR-γ) polymorphism (Pro12Ala) in Iranian population
por: Namvaran, Fatemeh, et al.
Publicado: (2011)

Peroxisome proliferator-activated receptor Pro12Ala polymorphism and the risks of gestational diabetes mellitus: An updated meta-analysis of 12 studies
por: Wang, Lihong, et al.
Publicado: (2016)

Association of Pro12Ala polymorphism in peroxisome proliferator activated receptor gamma with proliferative diabetic retinopathy
por: Tariq, Khadija, et al.
Publicado: (2013)

Peroxisome Proliferator–Activated Receptor γ Polymorphism Pro12Ala Is Associated With Nephropathy in Type 2 Diabetes: Evidence from meta-analysis of 18 studies
por: Zhang, Hui, et al.
Publicado: (2012)

Meta-analysis of association between the Pro12Ala polymorphism of the peroxisome proliferator–activated receptor-γ2 gene and diabetic retinopathy in Caucasians and Asians
por: Ma, Jinlan, et al.
Publicado: (2012)

Effect of the Pro12Ala Polymorphism of the Peroxisome Proliferator-activated Receptor γ2 Gene on Lipid Profile and Adipokines Levels in Obese Subjects
por: Becer, E, et al.
Publicado: (2017)

Association between the Pro12Ala Polymorphism of the Peroxisome Proliferator-Activated Receptor Gamma Gene and Strength Athlete Status
por: Maciejewska-Karlowska, Agnieszka, et al.
Publicado: (2013)

PPARγ2(Pro12Ala) Polymorphism and Human Health
por: He, Weimin
Publicado: (2009)

Association between the Pro12Ala Polymorphism of Peroxisome Proliferator-Activated Receptor Gamma 2 and Inflammatory Bowel Disease: A Meta-Analysis
por: Zhang, Zhi-Feng, et al.
Publicado: (2012)

Effect of Proliferator-Activated Receptor-γ Pro12Ala Polymorphism on Colorectal Cancer Risk: A Meta-Analysis
por: Wei, Zhijiang, et al.
Publicado: (2015)

The Pro12Ala Polymorphism in the Peroxisome Proliferator-Activated Receptor Gamma-2 Gene (PPARγ2) Is Associated with Increased Risk of Coronary Artery Disease: A Meta-Analysis
por: Wu, Zhijun, et al.
Publicado: (2012)

Evaluation of single nucleotide polymorphisms of Pro12Ala in peroxisome proliferator-activated receptor-γ and Gly308Ala in tumor necrosis factor-α genes in obese Asian Indians: a population-based study
por: Bhagat, Namita, et al.
Publicado: (2010)

Distribution and genotype frequency of the C1431T and pro12ala polymorphisms of the peroxisome proliferator activator receptor gamma gene in an Iranian population
por: Rooki, Hassan, et al.
Publicado: (2013)

Pro12Ala polymorphism of peroxisome proliferator activated receptor gamma 2 may be associated with adverse neurodevelopment in European preterm babies
por: Victor, Suresh, et al.
Publicado: (2021)

Does Pro(12)Ala Polymorphism Enhance the Physiological Role of PPARγ2?
por: Pereira, A. C., et al.
Publicado: (2013)

Homozygosity for the Ala Allele of the PPARγ2 Pro12Ala Polymorphism Is Associated with Reduced Risk of Coronary Artery Disease
por: Galgani, Andrea, et al.
Publicado: (2010)

The Pro12Ala Polymorphism of the Peroxisome Proliferator-Activated Receptor Gamma Gene Modifies the Association of Physical Activity and Body Mass Changes in Polish Women
por: Zarebska, Aleksandra, et al.
Publicado: (2014)

Role of peroxisome proliferator-activated receptor gamma Pro12Ala polymorphism in human adipose tissue: assessment of adipogenesis and adipocyte glucose and lipid turnover
por: Kamble, Prasad G., et al.
Publicado: (2018)

Breast-Feeding Modulates the Influence of the Peroxisome Proliferator–Activated Receptor-γ (PPARG2) Pro12Ala Polymorphism on Adiposity in Adolescents: The Healthy Lifestyle in Europe by Nutrition in Adolescence (HELENA) cross-sectional study
por: Verier, Caroline, et al.
Publicado: (2010)

Association of PPARγ2 gene variant Pro12Ala polymorphism with hypertension and obesity in the aboriginal Qatari population known for being consanguineous
por: Bener, Abdulbari, et al.
Publicado: (2013)

PPARγ Pro(12)Ala polymorphism and risk of acute coronary syndrome in a prospective study of Danes
por: Vogel, Ulla, et al.
Publicado: (2009)

PPARγ Pro12Ala and ACE ID polymorphisms are associated with BMI and fat distribution, but not metabolic syndrome
por: Passaro, Angela, et al.
Publicado: (2011)

The Pro12Ala Polymorphism of PPAR-γ Gene Is Associated with Sepsis Disease Severity and Outcome in Chinese Han Population
por: Ma, Guoda, et al.
Publicado: (2014)

The Association Between the Peroxisome Proliferator-Activated Receptor-γ2 (PPARG2) Pro12Ala Gene Variant and Type 2 Diabetes Mellitus: A HuGE Review and Meta-Analysis
por: Gouda, Hebe N., et al.
Publicado: (2010)

Comment on: Zhang et al. Peroxisome Proliferator–Activated Receptor γ Polymorphism Pro12Ala Is Associated With Nephropathy in Type 2 Diabetes: Evidence From Meta-Analysis of 18 Studies. Diabetes Care 2012;35:1388–1393
por: Lapice, Emanuela, et al.
Publicado: (2013)

Impact of the Pro12Ala polymorphism of the PPARγ2 gene on diabetes and obesity in a highly consanguineous population
por: Bener, Abdulbari, et al.
Publicado: (2015)

PPARγ2 Pro12Ala Polymorphism is Associated in Children With Traits Related to Susceptibility to Type 2 Diabetes
por: Vales-Villamarín, Claudia, et al.
Publicado: (2021)

Association between PRO12ALA polymorphism of the PPAR-γ2 gene and type 2 diabetes mellitus in Iranian patients
por: Motavallian, Azadeh, et al.
Publicado: (2013)

The Association of PPARγ Pro12Ala and C161T Polymorphisms with Polycystic Ovary Syndrome and Their Influence on Lipid and Lipoprotein Profiles
por: Rahimi, Zohreh, et al.
Publicado: (2018)

Effects Of PPARγ2 Pro12Ala Variant On Adipocyte Phenotype Dependent Of DHA
por: Wan, Renhui, et al.
Publicado: (2019)

Breast-Feeding Modifies the Association of PPARγ2 Polymorphism Pro12Ala With Growth in Early Life: The Generation R Study
por: Mook-Kanamori, Dennis O., et al.
Publicado: (2009)

Changes in bone biological markers after treatment of Iranian diabetic patients with pioglitazone: No relation to polymorphism of PPAR-γ (Pro12Ala)
por: Namvaran, Fatemeh, et al.
Publicado: (2013)

Changes in bone biological markers after treatment of Iranian diabetic patients with pioglitazone: No relation to polymorphism of PPAR-γ (Pro12Ala)
por: Mottaghi, Peyman
Publicado: (2013)

The Pro12Ala polymorphism in the PPAR-γ2 gene is not associated to obesity and type 2 diabetes mellitus in a Cameroonian population
por: Mato, Edith Pascale M., et al.
Publicado: (2016)

Assessment of the Pro12Ala Polymorphism in the PPAR-γ2 Gene among Type 2 Diabetes Patients in a Nigerian Population
por: Engwa, Godwill Azeh, et al.
Publicado: (2018)

Pro12Ala Polymorphism on the PPAR(γ)2 Gene and Weight Loss After Aerobic Training: A Randomized Controlled Trial
por: Cardoso, Glêbia Alexa, et al.
Publicado: (2020)

Association of PPARγ2 (Pro12Ala) and Neuropeptide Y (Leu7Pro) Gene Polymorphisms with Obstructive Sleep Apnea in Obese Asian Indians
por: Bhushan, Bharat, et al.
Publicado: (2011)

Association of the Pro12Ala Polymorphism with the Metabolic Parameters in Women with Polycystic Ovary Syndrome
por: Zaki, Moushira, et al.
Publicado: (2017)

Association between Pro12Ala polymorphism and albuminuria in type 2 diabetic nephropathy
por: Chen, Yung‐Nien, et al.
Publicado: (2020)

The Pro12Ala polymorphism in the PPARγ2 gene is not associated with an increased risk of NAFLD in Iranian patients with type 2 diabetes mellitus
por: Saremi, Leila, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_f9g7l361991lpbrvj2cuo8naki